Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T12:05:20.737Z.
Calculation as of: 2026-10-06T12:05:20.737Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5c9508078213b28dfeff6809371853141f28b2786ea2d18fc4f82dd6840af9a4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Advanced Biomed Inc. Common Stock
Market Cap
$8.76M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.03M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.76M
EV/EBIT Ratio
N/A
TTM Avg
1748.82x
3Y Avg
1748.82x
5Y Avg
1748.82x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Advanced Biomed Inc. Common Stock (ADVB) | $8.76M | N/A | N/A | N/A | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.37M | N/A | N/A | N/A | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | N/A | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.79M | N/A | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.27M | N/A | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.03M | N/A | N/A | N/A | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | N/A | 1.45x | 7.74x | 7.74x |
| Cerenome, Inc. (CNSY)vs › | $10.74M | N/A | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | N/A | 1748.82x | 1748.82x | 1748.82x |
| Aclarion, Inc. (ACON)vs › | $6.74M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
